Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pretarsal vs Preseptal Botox for Eyelid Spasm
NCT03508882Phase 4Completed
- Sponsor
- The University of Hong Kong
- Start
- Jul 2015
- Primary completion
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, triple-blind trial of botulinum toxin type A in benign essential blepharospasm (BEB) and hemifacial spasm (HFS), sponsored by The University of Hong Kong. Primary endpoint: Jankovic Rating Scale at 10 months. Started Jul 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
benign essential blepharospasm (BEB)hemifacial spasm (HFS)
Beyond the preview
Go deeper on NCT03508882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03508882.